SPEECH BY THE HON. LOUIS DEGUARA, MINISTER OF HEALTH, THE ELDERLY AND COMMUNITY CARE, AT THE MEDICINES AUTHORITY SEMINAR ON “IMPROVED PUBLIC HEALTH THROUGH MEDICINES REGULATION” – ST. JULIAN’S - 14TH OCTOBER, 2004
Distinguished guests,
Colleagues,
It is indeed my pleasure to be gathered here with such distinguished guests in order to officially close the Twinning Project that has been extremely valuable in assisting Malta to set up the necessary competent authority to regulate medicines. The funding for this project, 850,000 Euros, was made possible through pre-accession funds given to Malta in order to gear up for EU membership. In the area of medicines regulation, Malta had to implement significant changes in order to attain the levels required out of a Member State of the European Union. I am most glad to say that we have successfully bridged the gap and have now assumed the functions of a competent authority for medicines regulation.
I am pleased to note that Mr Philippe Brunet from the Commission has traveled specifically to be with us here today. I extend my warmest welcome to him as well as to our distinguished guests from the Irish Medicines Board and the Medicines and Health Care Regulatory Agency of the United Kingdom .
I would like to extend my thanks to the sister authorities of Ireland and the United Kingdom for the support that they have given us to enable us to set up a structure and systems that guarantees the highest attainable levels of quality, safety and efficacy of medicines for the Maltese market. I am sure that today by no means marks the end of our cooperation but is merely the passage into a new level of cooperation, that which like-minded Member States extend to each other in all the European bodies and committees.
I am convinced that the links that have been built between the technical experts in our authority and those of Ireland and the United Kingdom will continue to be most useful as Malta learns how to navigate through the complex European processes that are required in the field of medicines regulation. In this respect I feel that Twinning as an instrument is particularly valuable and I am looking forward to the new twinning projects under our Ministry in the areas of blood safety and public health. These are due to commence next year and are funded by the European Union “transition facility”.
I am aware that this twinning project faced numerous challenges, none of which however proved to be insurmountable. This is due to the commitment and unstinting efforts of all those directly involved with the project at the Medicines Authority as well as the support given behind the scenes by staff within the Health Division and Ministry itself. I know that much hard work has been carried out over the past year and a half and it is because of this extraordinary effort that we are here today to successfully wrap up this Twinning Project and to officially launch the new set up for medicines regulation in Malta .
Allow me to dwell for a few moments on the rationale for medicines regulation. As a Government we have believed in the need to institute standards for medicines regulation for years. The problem was the lack of local expertise and the investment required. As a result of this twinning project, we were able to overcome these barriers and forge ahead with implementing our vision.
We believe in medicines regulation because this affects the health of the public at large. In an era where almost everybody is consuming some kind of medicines at any point in their life, with the elderly often consuming a whole variety of medicines, it is of utmost importance to know that firstly, these medicines are not harmful and secondly that they are really effective in bringing about the desired results.
Quality comes at a cost. The cost we are presently facing is the disappearance of certain product brands from the local market and the replacement of some of these brands with more expensive alternatives. However in the interest of patient safety we believe that one cannot make compromises on the quality of medicines being consumed by the public in Malta.
We understand that the transition period poses difficult challenges both for the Medicines authority, as well as for health service providers and the industry. The only way we will succeed is if we all work together keeping public health and safety as our prime concern. I am pleased to note that one of the results of this project has been the building of closer ties with our stakeholders. I am sure that this new era of working together is now well established and set to continue.
As a Member of the European Union being represented on the various bodies and committees involved in European medicines regulation, our motto has been and shall continue to be “promoting effective yet simple medicines regulation in Europe.” We do not believe in excessive unjustified regulation that can have a negative impact on industry with no tangible benefit for patients, but are very strong supporters of the necessary safeguards for public health in Europe.
I am sure that this will be a most interesting morning for all of you present thank you for having invited me to share my thoughts with you on this most important topic for public health, namely medicines regulation.
DOI – 15.10.2004
10.54 Kbytes Last Modified on 15th October, 2004
HOME | GOV.MT
HELP | LINKS | SITEMAP | SEARCH
Other Press Releases:
PR261946
STQARRIJA MILL-MINISTERU GĦALL-EDUKAZZJONI U L-ISPORT Aktar minn 1,800 stu...
PR261945